Streptozotocin

Overview

Streptozotocin is antineoplastic antibiotic derived from Streptomyces achromogenes or produced by chemical synthesis. Streptozotocin is the drug of choice in the of treatment of malignant pancreatic insulinomas and malignant carcinoid tumors (especially when given along with Fluorouracil). Streptozotocin is also effective in the treatment of Hodgkin`s disease and for colon cancer, when used in combination with other anticancer drugs.

Categories

Primary Characterstics

Indications

Back to top

Pharmacokinetics

Back to top

Contraindications

Back to top

Drug Interactions

Back to top

Side Effects

Back to top

Dosage

Streptozotocin's dosage details are as follows:
Dose Single Dose Frequency Route Instructions

Adult Dosage

500 mg/sq.meter920 (916)24 hourlyIVFor 5 Days

Paedriatic Dosage (20kg)

No data regarding the Paedriatic dosage details of Streptozotocin is available.

Neonatal Dosage (3kg)

No data regarding the neonatal dosage details of Streptozotocin is available.

High Risk Groups

Back to top

Warning / Precautions

Back to top

Storage Conditions

Back to top

Interference in Pathology

Back to top

Brands / Trade Names of Streptozotocin

Back to top

Manufacturers of Streptozotocin in Pakistan

Back to top

Previous Drug Generic - Next Drug Generic


Suggested Pages